Rubicon Research
add_icon

Rubicon Research

780.10
-12.30
(-1.55%)
Market Cap
12,852.17 Cr
PE Ratio
63.25
Volume
1,14,497.00
Day High - Low
799.35 - 774.45
52W High-Low
822.00 - 570.75
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
12,852.17 Cr
EPS
8.82
PE Ratio
63.25
PB Ratio
11.37
Book Value
76.31
EBITDA
267.90
Dividend Yield
0.00 %
Industry
Healthcare
Return on Equity
24.84
Debt to Equity
0.91
Analyst Rating and Forecast
- By Refinitiv from1 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+100.00 %
+100.00 %
Hold
Hold0.0 %
0.0 %
Sell
Sell0.0 %
0.0 %
Forecast For
Actual

Company News

View All News
Caret
neutral
Rubicon Research Limited seeks shareholder approval through postal ballot for appointing Dr. Pradnya Saravade as Independent Woman Director and M/s. BNP & Associates as Secretarial Auditors. E-voting period: February 14-March 15, 2026.
positive
Rubicon Research reported strong Q3 performance with consolidated net profit rising 91% YoY to ₹728 million, while revenue grew 52% to ₹4.76 billion compared to previous year.
positive
Rubicon Research Limited's board approved appointment of Dr. Pradnya Saravade as Independent Woman Director, resignation of Mr. Anand Agarwal, new secretarial auditor appointment, and merger approval with subsidiary KIA Health Tech.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,724.40
#1 4,13,741.32
37.53
#1 54,729.00
9.71
#1 10,980
16.07
58.16
6,291.00
1,67,006.28
67.40
9,712.00
18.67
2,191
-1.02
53.89
4,241.70
1,43,558.40
62.90
11,539.40
6.99
1,911
26.24
66.58
1,341.10
1,08,330.28
23.68
28,409.50
7.12
5,291
-57.18
43.41
1,280.40
1,06,866.07
19.34
33,741.20
16.73
5,725
-15.28
60.10
2,219.40
1,01,381.93
21.81
22,909.50
13.74
3,306
#1 37.44
57.52
900.75
90,636.53
#1 18.06
23,511.00
18.55
4,615
-0.32
49.52
2,024.30
83,564.13
46.65
12,744.20
#1 20.90
2,007
7.65
38.95
1,158.80
67,303.29
19.60
32,345.60
9.43
3,484
7.59
47.48
5,392.00
64,469.45
26.53
13,458.30
3.70
2,216
1.90
37.57

Automatic Screeners on ScanX

Growth Rate
Revenue Growth
48.58 %
Net Income Growth
47.69 %
Cash Flow Change
657.64 %
ROE
5.08 %
ROCE
39.15 %
EBITDA Margin (Avg.)
4.18 %

Quarterly Financial Results

Quarterly Financials
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Revenue
317
299
314
358
353
413
479
Expenses
257
234
244
286
273
318
367
EBITDA
61
64
70
73
80
95
112
Operating Profit %
19 %
21 %
22 %
20 %
22 %
23 %
23 %
Depreciation
9
8
9
10
10
12
12
Interest
10
7
8
12
11
11
10
Profit Before Tax
41
49
53
51
60
72
91
Tax
16
15
15
15
16
18
18
Net Profit
26
35
38
36
43
54
73
EPS in ₹
1.66
2.27
2.50
2.35
2.81
3.49
4.46

Balance Sheet

Balance Sheet
2020
2021
2022
2023
2024
2025
Total Assets
430
538
560
750
1,110
1,451
Fixed Assets
157
188
193
199
307
327
Current Assets
265
340
328
502
763
1,063
Capital Work in Progress
2
6
3
25
10
7
Investments
19
14
0
0
0
0
Other Assets
252
331
364
526
793
1,118
Total Liabilities
430
538
560
750
1,110
1,451
Current Liabilities
78
111
184
361
573
786
Non Current Liabilities
12
53
71
102
152
124
Total Equity
341
374
305
286
385
541
Reserve & Surplus
335
369
300
281
370
526
Share Capital
5
5
5
5
15
15

Cash Flow

Cash Flow
2020
2021
2022
2023
2024
2025
Net Cash Flow
1
67
-46
16
-4
54
Investing Activities
-84
-46
-46
-32
-68
-65
Operating Activities
6
62
-63
-75
21
159
Financing Activities
80
52
63
123
44
-40

Share Holding

% Holding
Jul 2024
Sept 2025
Oct 2025
Dec 2025
Promoter
84.15 %
59.99 %
59.99 %
59.99 %
FIIs
0.00 %
9.37 %
9.37 %
7.99 %
DIIs
0.00 %
10.54 %
10.54 %
9.45 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
18.28 %
18.28 %
2.71 %
Others
15.85 %
1.82 %
1.82 %
19.86 %
No of Share Holders
15
1,05,311
1,05,311
31,914

Dividend History

Annual Cash Flows 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
13 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
13 Nov 2025 638.50 627.25
03 Feb 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
03 Feb 2026 650.05 688.90

Announcements

Announcement under Regulation 30 (LODR)-Newspaper Publication5 days ago
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot9 days ago
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 06, 2026
Newspaper Publication - Financial ResultsFeb 05, 2026
General UpdatesFeb 03, 2026
Announcement Under Regulation 30 - Appointment Of Secretarial AuditorFeb 03, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementFeb 03, 2026
Announcement under Regulation 30 (LODR)-Resignation of DirectorFeb 03, 2026
Board Meeting Outcome for Outcome Of The Board Meeting Held On Tuesday February 03 2026Feb 03, 2026
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportFeb 03, 2026
Results - Financial Results For 31-12-2025Feb 03, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationFeb 03, 2026
Intimation Under Regulation 30 Read With Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jan 30, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 28, 2026
Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company Will Be Held On Tuesday 03Rd February 2026 Inter-Alia To Consider And Approve The Unaudited Standalone And Consolidated Financial Results For The Quarter And Nine Months Ended 3Jan 27, 2026
Announcement under Regulation 30 (LODR)-AcquisitionJan 14, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementJan 09, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 09, 2026
Intimation Under Regulation 30 Of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015Jan 06, 2026
Closure of Trading WindowDec 29, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportDec 08, 2025
Intimation For Updation Of Corporate Identification Number ("CIN") Of The CompanyNov 20, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 18, 2025
Newspaper Publication - Financial ResultsNov 14, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Held On Thursday 13Th November 2025Nov 13, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationNov 13, 2025
Results-Financial Results For 30-09-2025Nov 13, 2025
Reporting Of Violations Under SEBI (Prohibition Of Insider Trading) Regulations 2015.Nov 13, 2025
Newspaper Publication - Notice Of Postal BallotNov 08, 2025
Notice Of Postal BallotNov 07, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 07, 2025
Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company To Be Held On Thursday 13Th November 2025.Nov 07, 2025
Announcement under Regulation 30 (LODR)-AcquisitionOct 28, 2025
Announcement under Regulation 30 (LODR)-AcquisitionOct 21, 2025
Closure of Trading WindowOct 17, 2025
Listing of Equity Shares of Rubicon Research LtdOct 16, 2025

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Bajaj Finserv Small Cap Fund Direct-Growth
2.14%
250730
1.13%
2.14%
Kotak Healthcare Fund Direct - Growth
1.56%
0
0.00%
0.06%
HDFC Pharma And Healthcare Fund Direct - Growth
1.16%
0
0.00%
0.07%
Bajaj Finserv Multi Asset Allocation Fund Direct-Growth
0.79%
0
0.00%
-0.11%
Bajaj Finserv Flexi Cap Fund Direct-Growth
0.47%
0
0.00%
0.46%
Canara Robeco Manufacturing Fund Direct - Growth
1.69%
0
0.00%
0.09%
Edelweiss Recently Listed IPO Fund Direct-Growth
1.47%
0
0.00%
0.12%
HDFC Business Cycle Fund Direct - Growth
0.00%
0
0.00%
-0.27%
Kotak Manufacture in India Fund Direct - Growth
2.32%
0
0.00%
0.09%
Bajaj Finserv Balanced Advantage Fund Direct-Growth
0.61%
0
0.00%
0.08%
ICICI Prudential Exports and Services Fund Direct-Growth
0.76%
0
0.00%
0.03%
Bajaj Finserv Healthcare Fund Direct-Growth
3.33%
0
0.00%
0.22%
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct - Growth
0.74%
0
0.00%
-0.02%
HDFC Innovation Fund Direct-Growth
1.30%
0
0.06%
0.14%
Kotak Midcap Fund Direct-Growth
0.40%
0
0.00%
0.02%
Mirae Asset Healthcare Fund Direct - Growth
0.97%
0
0.00%
0.05%
Motilal Oswal Small Cap Fund Direct - Growth
3.01%
0
0.00%
0.32%
PGIM India ELSS Tax Saver Fund Direct-Growth
0.91%
0
0.00%
0.05%
PGIM India Flexi Cap Fund Direct-Growth
0.32%
0
0.00%
0.01%
PGIM India Healthcare Fund Direct-Growth
5.00%
0
0.00%
0.39%
PGIM India Large and Mid Cap Fund Direct - Growth
0.78%
0
0.00%
-0.53%
PGIM India Multi Asset Allocation Fund Direct - Growth
0.36%
0
-0.09%
0.36%
PGIM India Multi Cap Fund Direct-Growth
1.40%
0
0.00%
-0.18%
PGIM India Retirement Fund Direct - Growth
1.46%
0
0.00%
0.05%

Technical Indicators

RSI(14)
Neutral
63.85
ATR(14)
Less Volatile
28.05
STOCH(9,6)
Neutral
57.99
STOCH RSI(14)
Neutral
43.63
MACD(12,26)
Bullish
0.29
ADX(14)
Strong Trend
34.30
UO(9)
Bearish
45.24
ROC(12)
Uptrend And Accelerating
0.79
WillR(14)
Neutral
-33.79